September 30, 2021

Accenture Named a Leader in the IDC MarketScape: Worldwide Life Science R&D BPO Services 2021 Vendor Assessment

NEW YORK; Sept. 30, 2021 – Accenture (NYSE: ACN) has been named a Leader in life science research and development (R&D) and business process outsourcing (BPO) services capabilities, according to a new a worldwide IDC MarketScape assessment.

The report, IDC MarketScape: Worldwide Life Science R&D BPO Services 2021 Vendor Assessment (doc #US48126821, August 2021) is the first of a three-part IDC MarketScape series focused on services in life science R&D. This study evaluates major vendors using criteria that should be important to life science companies when considering the selection of an external service provider to take over noncore business processes.

The report notes that “Accenture brings to bear its expertise in building agile, lean, digitally enabled business models, its strategic consulting expertise, and its liquid plug-and-play platform, myWizard, driving AI-driven automation, as well as its INTIENT platform, a Google cloud-based open architecture technology platform, powered by Accenture Applied Intelligence, to support its BPO services.”

Building further on unique platform capabilities like INTIENT, the report cites SynOps as another significant asset. According to the IDC MarketScape, the operations platform brings together the best innovative digital technologies, process, and industry expertise to create an evolved working environment, driven by data and analytics.

Accenture is also recognized in the report for being a shared services organization, able to deliver clinical, regulatory, and safety operations through a common pool of talent, standard processes and assets. The IDC MarketScape notes this model helps Accenture to provide services to more than 200 small and medium-sized clients.

Dr. Nimita Limaye, research VP, Life Science R&D Strategy and Technology, at IDC, said, “What differentiates Accenture is its strong BPO team and the ability to weave technology into its BPO offerings combined with a depth of experience in managing trials and submissions across the globe. It is not surprising that a global pharma executive recently told IDC that: ‘Accenture has an outstanding BPO model, with shared vision and outcome, productivity, and quality built into the contract.’”

Tom Lehmann, who leads Life Sciences R&D at Accenture, added: “Working together with our clients to provide technology enabled BPO services for a wide range of biopharma organizations around the globe is an exciting part of our broader R&D services and solutions. Our BPO relationships are at the core of our clients’ clinical development, regulatory and pharmacovigilance processes and position us to
to help develop and gain regulatory approval for the new products and treatments that benefit patients, while also directly supporting the required compliance requirements for approved products.”

An excerpt of the “IDC MarketScape: Worldwide Life Science R&D BPO Services 2021 Vendor Assessment,” is available here.

About IDC MarketScape:
IDC MarketScape vendor assessment model is designed to provide an overview of the competitive fitness of ICT (information and communications technology) suppliers in a given market. The research methodology utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor’s position within a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of IT and telecommunications vendors can be meaningfully compared. The framework also provides technology buyers with a 360-degree assessment of the strengths and weaknesses of current and prospective vendors.

Accenture’s Life Sciences industry group helps pharmaceutical, biotech, medical technology, distributor and consumer health companies combine the latest technology with scientific breakthroughs to revolutionize how medical treatments are discovered, developed and delivered to patients around the world. To learn more, visit

About Accenture
Accenture is a global professional services company with leading capabilities in digital, cloud and security. Combining unmatched experience and specialized skills across more than 40 industries, we offer Strategy and Consulting, Interactive, Technology and Operations services — all powered by the world’s largest network of Advanced Technology and Intelligent Operations centers. Our 624,000 people deliver on the promise of technology and human ingenuity every day, serving clients in more than 120 countries. We embrace the power of change to create value and shared success for our clients, people, shareholders, partners and communities. Visit us at

# # #


Marchell Gillis
+1 678 657 7515

Copyright ©2021 Accenture. All rights reserved. Accenture and its logo are registered trademarks of Accenture.